No Cover Image

Journal article 703 views

CYP56 (Dit2p) in Candida albicans: Characterization and Investigation of Its Role in Growth and Antifungal Drug Susceptibility

N. R Melo, G. P Moran, Andrew Warrilow, Ed Dudley, S. N Smith, D. J Sullivan, D. C Lamb, Diane Kelly, D. C Coleman, Steven Kelly Orcid Logo

Antimicrobial Agents and Chemotherapy, Volume: 52, Issue: 10, Pages: 3718 - 3724

Swansea University Authors: Andrew Warrilow, Ed Dudley, Diane Kelly, Steven Kelly Orcid Logo

Full text not available from this repository: check for access using links below.

Check full text

DOI (Published version): 10.1128/AAC.00446-08

Published in: Antimicrobial Agents and Chemotherapy
ISSN: 0066-4804 1098-6596
Published: 2008
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa6349
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2013-07-23T11:54:33Z
last_indexed 2021-10-27T02:17:53Z
id cronfa6349
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2021-10-26T14:13:18.0072660</datestamp><bib-version>v2</bib-version><id>6349</id><entry>2011-10-01</entry><title>CYP56 (Dit2p) in Candida albicans: Characterization and Investigation of Its Role in Growth and Antifungal Drug Susceptibility</title><swanseaauthors><author><sid>f066e233e8d0136c9f547b86fa43747f</sid><firstname>Andrew</firstname><surname>Warrilow</surname><name>Andrew Warrilow</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>c7d05f992a817cd3b9a5f946bd909b71</sid><firstname>Ed</firstname><surname>Dudley</surname><name>Ed Dudley</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>5ccf81e5d5beedf32ef8d7c3d7ac6c8c</sid><firstname>Diane</firstname><surname>Kelly</surname><name>Diane Kelly</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>b17cebaf09b4d737b9378a3581e3de93</sid><ORCID>0000-0001-7991-5040</ORCID><firstname>Steven</firstname><surname>Kelly</surname><name>Steven Kelly</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2011-10-01</date><deptcode>FGMHL</deptcode><abstract/><type>Journal Article</type><journal>Antimicrobial Agents and Chemotherapy</journal><volume>52</volume><journalNumber>10</journalNumber><paginationStart>3718</paginationStart><paginationEnd>3724</paginationEnd><publisher/><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>0066-4804</issnPrint><issnElectronic>1098-6596</issnElectronic><keywords/><publishedDay>31</publishedDay><publishedMonth>12</publishedMonth><publishedYear>2008</publishedYear><publishedDate>2008-12-31</publishedDate><doi>10.1128/AAC.00446-08</doi><url/><notes/><college>COLLEGE NANME</college><department>Medicine, Health and Life Science - Faculty</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>FGMHL</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2021-10-26T14:13:18.0072660</lastEdited><Created>2011-10-01T00:00:00.0000000</Created><path><level id="1">Swansea University Medical School</level><level id="2">Medicine</level></path><authors><author><firstname>N. R</firstname><surname>Melo</surname><order>1</order></author><author><firstname>G. P</firstname><surname>Moran</surname><order>2</order></author><author><firstname>Andrew</firstname><surname>Warrilow</surname><order>3</order></author><author><firstname>Ed</firstname><surname>Dudley</surname><order>4</order></author><author><firstname>S. N</firstname><surname>Smith</surname><order>5</order></author><author><firstname>D. J</firstname><surname>Sullivan</surname><order>6</order></author><author><firstname>D. C</firstname><surname>Lamb</surname><order>7</order></author><author><firstname>Diane</firstname><surname>Kelly</surname><order>8</order></author><author><firstname>D. C</firstname><surname>Coleman</surname><order>9</order></author><author><firstname>Steven</firstname><surname>Kelly</surname><orcid>0000-0001-7991-5040</orcid><order>10</order></author></authors><documents/><OutputDurs/></rfc1807>
spelling 2021-10-26T14:13:18.0072660 v2 6349 2011-10-01 CYP56 (Dit2p) in Candida albicans: Characterization and Investigation of Its Role in Growth and Antifungal Drug Susceptibility f066e233e8d0136c9f547b86fa43747f Andrew Warrilow Andrew Warrilow true false c7d05f992a817cd3b9a5f946bd909b71 Ed Dudley Ed Dudley true false 5ccf81e5d5beedf32ef8d7c3d7ac6c8c Diane Kelly Diane Kelly true false b17cebaf09b4d737b9378a3581e3de93 0000-0001-7991-5040 Steven Kelly Steven Kelly true false 2011-10-01 FGMHL Journal Article Antimicrobial Agents and Chemotherapy 52 10 3718 3724 0066-4804 1098-6596 31 12 2008 2008-12-31 10.1128/AAC.00446-08 COLLEGE NANME Medicine, Health and Life Science - Faculty COLLEGE CODE FGMHL Swansea University 2021-10-26T14:13:18.0072660 2011-10-01T00:00:00.0000000 Swansea University Medical School Medicine N. R Melo 1 G. P Moran 2 Andrew Warrilow 3 Ed Dudley 4 S. N Smith 5 D. J Sullivan 6 D. C Lamb 7 Diane Kelly 8 D. C Coleman 9 Steven Kelly 0000-0001-7991-5040 10
title CYP56 (Dit2p) in Candida albicans: Characterization and Investigation of Its Role in Growth and Antifungal Drug Susceptibility
spellingShingle CYP56 (Dit2p) in Candida albicans: Characterization and Investigation of Its Role in Growth and Antifungal Drug Susceptibility
Andrew Warrilow
Ed Dudley
Diane Kelly
Steven Kelly
title_short CYP56 (Dit2p) in Candida albicans: Characterization and Investigation of Its Role in Growth and Antifungal Drug Susceptibility
title_full CYP56 (Dit2p) in Candida albicans: Characterization and Investigation of Its Role in Growth and Antifungal Drug Susceptibility
title_fullStr CYP56 (Dit2p) in Candida albicans: Characterization and Investigation of Its Role in Growth and Antifungal Drug Susceptibility
title_full_unstemmed CYP56 (Dit2p) in Candida albicans: Characterization and Investigation of Its Role in Growth and Antifungal Drug Susceptibility
title_sort CYP56 (Dit2p) in Candida albicans: Characterization and Investigation of Its Role in Growth and Antifungal Drug Susceptibility
author_id_str_mv f066e233e8d0136c9f547b86fa43747f
c7d05f992a817cd3b9a5f946bd909b71
5ccf81e5d5beedf32ef8d7c3d7ac6c8c
b17cebaf09b4d737b9378a3581e3de93
author_id_fullname_str_mv f066e233e8d0136c9f547b86fa43747f_***_Andrew Warrilow
c7d05f992a817cd3b9a5f946bd909b71_***_Ed Dudley
5ccf81e5d5beedf32ef8d7c3d7ac6c8c_***_Diane Kelly
b17cebaf09b4d737b9378a3581e3de93_***_Steven Kelly
author Andrew Warrilow
Ed Dudley
Diane Kelly
Steven Kelly
author2 N. R Melo
G. P Moran
Andrew Warrilow
Ed Dudley
S. N Smith
D. J Sullivan
D. C Lamb
Diane Kelly
D. C Coleman
Steven Kelly
format Journal article
container_title Antimicrobial Agents and Chemotherapy
container_volume 52
container_issue 10
container_start_page 3718
publishDate 2008
institution Swansea University
issn 0066-4804
1098-6596
doi_str_mv 10.1128/AAC.00446-08
college_str Swansea University Medical School
hierarchytype
hierarchy_top_id swanseauniversitymedicalschool
hierarchy_top_title Swansea University Medical School
hierarchy_parent_id swanseauniversitymedicalschool
hierarchy_parent_title Swansea University Medical School
department_str Medicine{{{_:::_}}}Swansea University Medical School{{{_:::_}}}Medicine
document_store_str 0
active_str 0
published_date 2008-12-31T03:16:28Z
_version_ 1737024223220596736
score 10.887713